Report: Exploring Fundamental Drivers Behind Seritage Growth Properties, Forrester Research, Chemours, MoSys, Malibu Boats, and Aratana Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments

NEW YORK, Oct. 11, 2018 — In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Seritage Growth Properties (NYSE:SRG), Forrester Research, Inc. (NASDAQ:FORR), Chemours Company (NYSE:CC), MoSys, Inc. (NASDAQ:MOSY), Malibu Boats, Inc. (NASDAQ:MBUU), and Aratana Therapeutics, Inc. (NASDAQ:PETX), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

SRG DOWNLOAD: http://MarketSourceResearch.com/register/?so=SRG FORR DOWNLOAD: http://MarketSourceResearch.com/register/?so=FORR CC DOWNLOAD: http://MarketSourceResearch.com/register/?so=CC MOSY DOWNLOAD: http://MarketSourceResearch.com/register/?so=MOSY MBUU DOWNLOAD: http://MarketSourceResearch.com/register/?so=MBUU PETX DOWNLOAD: http://MarketSourceResearch.com/register/?so=PETX

 Stay Updated To Save Money & Time. Join Our Free Newsletter 
. Indepth Analysis & Opinion       . Interviews      . Exclusive Reports  
. Free Digital Magazines      News & updates      . Event Invitations 
                     
& Much More Delivered To Your Inbox For Free.
Submit
We Will Not Spam, Rent, or Sell Your Information.
All emails include an unsubscribe link. You may opt-out at any time. See our privacy policy.

 

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine Seritage Growth Properties (NYSE:SRG), Forrester Research, Inc. (NASDAQ:FORR), Chemours Company (NYSE:CC), MoSys, Inc. (NASDAQ:MOSY), Malibu Boats, Inc. (NASDAQ:MBUU), and Aratana Therapeutics, Inc. (NASDAQ:PETX) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

—————————————–

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed October 9th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

—————————————–

SERITAGE GROWTH PROPERTIES (SRG) REPORT OVERVIEW

Seritage Growth Properties’ Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Seritage Growth Properties reported revenue of $49.27MM vs $57.89MM (down 14.89%) and analysts estimated basic earnings per share -$0.23 vs -$0.63. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Seritage Growth Properties reported revenue of $241.02MM vs $248.67MM (down 3.08%) and analysts estimated basic earnings per share -$2.19 vs -$1.64. Analysts expect earnings to be released on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018.

To read the full Seritage Growth Properties (SRG) report, download it here: http://MarketSourceResearch.com/register/?so=SRG

—————————————–

FORRESTER RESEARCH, INC. (FORR) REPORT OVERVIEW

Forrester Research’s Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Forrester Research reported revenue of $96.35MM vs $89.73MM (up 7.38%) and analysts estimated basic earnings per share $0.43 vs $0.34 (up 26.47%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Forrester Research reported revenue of $337.67MM vs $326.10MM (up 3.55%) and analysts estimated basic earnings per share $0.84 vs $0.98 (down 14.29%). Analysts expect earnings to be released on October 24th, 2018. The report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was $0.22. The estimated EPS forecast for the next fiscal year is $1.21 and is expected to report on February 6th, 2019.

To read the full Forrester Research, Inc. (FORR) report, download it here: http://MarketSourceResearch.com/register/?so=FORR

—————————————–

CHEMOURS COMPANY (CC) REPORT OVERVIEW

Chemours’ Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Chemours reported revenue of $1,816.00MM vs $1,588.00MM (up 14.36%) and analysts estimated basic earnings per share $1.58 vs $0.87 (up 81.61%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Chemours reported revenue of $6,183.00MM vs $5,400.00MM (up 14.50%) and analysts estimated basic earnings per share $4.04 vs $0.04 (up 10,000.00%). Analysts expect earnings to be released on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was $1.12. The estimated EPS forecast for the next fiscal year is $5.97 and is expected to report on February 13th, 2019.

To read the full Chemours Company (CC) report, download it here: http://MarketSourceResearch.com/register/?so=CC

—————————————–

MOSYS, INC. (MOSY) REPORT OVERVIEW

MoSys’ Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, MoSys reported revenue of $4.60MM vs $1.38MM (up 232.23%) and basic earnings per share $0.04 vs -$0.60. For the twelve months ended December 31st, 2017 vs December 31st, 2016, MoSys reported revenue of $8.84MM vs $6.02MM (up 46.78%) and analysts estimated basic earnings per share -$1.45 vs -$4.86. Analysts expect earnings to be released on November 12th, 2018. The report will be for the fiscal period ending September 30th, 2018.

To read the full MoSys, Inc. (MOSY) report, download it here: http://MarketSourceResearch.com/register/?so=MOSY

—————————————–

MALIBU BOATS, INC. (MBUU) REPORT OVERVIEW

Malibu Boats’ Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Malibu Boats reported revenue of $138.66MM vs $75.11MM (up 84.62%) and analysts estimated basic earnings per share $0.61 vs $0.54 (up 12.96%). For the twelve months ended June 30th, 2018 vs June 30th, 2017, Malibu Boats reported revenue of $497.00MM vs $281.94MM (up 76.28%) and analysts estimated basic earnings per share $1.37 vs $1.59 (down 13.84%). Analysts expect earnings to be released on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.40. The estimated EPS forecast for the next fiscal year is $3.86 and is expected to report on September 5th, 2019.

To read the full Malibu Boats, Inc. (MBUU) report, download it here: http://MarketSourceResearch.com/register/?so=MBUU

—————————————–

ARATANA THERAPEUTICS, INC. (PETX) REPORT OVERVIEW

Aratana Therapeutics’ Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Aratana Therapeutics reported revenue of $4.91MM vs $5.16MM (down 4.85%) and analysts estimated basic earnings per share -$0.14 vs -$0.26. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Aratana Therapeutics reported revenue of $25.57MM vs $38.55MM (down 33.66%) and analysts estimated basic earnings per share -$1.17 vs -$0.95. Analysts expect earnings to be released on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.21. The estimated EPS forecast for the next fiscal year is -$0.20 and is expected to report on March 12th, 2019.

To read the full Aratana Therapeutics, Inc. (PETX) report, download it here: http://MarketSourceResearch.com/register/?so=PETX

—————————————–

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today’s markets. Market Source Research’s team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that’s ahead of the curve. With insights on individual companies as well as sectors, readers get the industry’s best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research’s oversight and audit staff are registered analysts, brokers, and/or financial advisers (“Registered Members”) working within Equity Research, Media, and Compliance departments. Market Source Research’s roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research’s Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at [email protected]

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Hugo Moreau, Media Department Office: +1 (704) 343-6361 E-mail: [email protected]

© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected]

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

 Stay Updated To Save Money & Time. Join Our Free Newsletter 
. Indepth Analysis & Opinion       . Interviews      . Exclusive Reports  
. Free Digital Magazines      News & updates      . Event Invitations 
                     
& Much More Delivered To Your Inbox For Free.
Submit
We Will Not Spam, Rent, or Sell Your Information.
All emails include an unsubscribe link. You may opt-out at any time. See our privacy policy.

 
Close
Stay Updated To Save Money & Time. Join Our Free Newsletter. 
. Indepth Analysis & Opinion       Interviews          . Exclusive Reports 
. Free Digital Magazines        . News & updates        . Event Invitations
& Much More Delivered To Your Inbox For Free. 
Submit
We Will Not Spam, Rent, or Sell Your Information.
All emails include an unsubscribe link. You may opt-out at any time. See our privacy policy.
 
Close